ATE116860T1 - Pseudorabiesvirus-impfstoff. - Google Patents

Pseudorabiesvirus-impfstoff.

Info

Publication number
ATE116860T1
ATE116860T1 AT89201887T AT89201887T ATE116860T1 AT E116860 T1 ATE116860 T1 AT E116860T1 AT 89201887 T AT89201887 T AT 89201887T AT 89201887 T AT89201887 T AT 89201887T AT E116860 T1 ATE116860 T1 AT E116860T1
Authority
AT
Austria
Prior art keywords
pseudorabies virus
prv
virus vaccine
polypeptide
present
Prior art date
Application number
AT89201887T
Other languages
English (en)
Inventor
Christa Sibilla Schreurs
Thomas Christoph Mettenleiter
Artur Josef Simon
Noemi Lukacs
Hanns Joachim Rhiza
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE116860T1 publication Critical patent/ATE116860T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT89201887T 1988-08-01 1989-07-18 Pseudorabiesvirus-impfstoff. ATE116860T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88112479 1988-08-01

Publications (1)

Publication Number Publication Date
ATE116860T1 true ATE116860T1 (de) 1995-01-15

Family

ID=8199168

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89201887T ATE116860T1 (de) 1988-08-01 1989-07-18 Pseudorabiesvirus-impfstoff.

Country Status (6)

Country Link
US (2) US5196516A (de)
EP (1) EP0353809B1 (de)
JP (1) JPH02142737A (de)
AT (1) ATE116860T1 (de)
DE (1) DE68920502T2 (de)
ES (1) ES2069574T3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2667245B1 (fr) * 1990-10-01 1992-11-06 Rhone Merieux Association vaccinale contre les pathogenes infectieux.
US6350583B1 (en) 1997-09-09 2002-02-26 Abbott Laboratories Reagents and methods useful for detecting diseases of the prostate
DE19757767A1 (de) * 1997-12-23 1999-07-15 Dade Behring Marburg Gmbh Immunreaktive Bereiche des Glycoproteins gpII des Varicella-Zoster-Virus (VZV)
US6068974A (en) * 1998-04-29 2000-05-30 Klann; Richard Chris Specific, highly sensitive, nested PCR detection scheme for the pseudorabies virus
CN105814077B (zh) * 2013-12-12 2019-07-26 赛特瑞恩股份有限公司 能够中和狂犬病毒的结合分子
CN105693827B (zh) * 2015-06-29 2020-05-15 普莱柯生物工程股份有限公司 一种猪伪狂犬病病毒亚单位疫苗及其制备方法和应用
BR112022010825A2 (pt) 2019-12-20 2022-08-23 Intervet Int Bv Vacina de vetor hvt multivalente

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0162738A1 (de) * 1984-04-09 1985-11-27 MOLECULAR GENETICS RESEARCH & DEVELOPMENT LIMITED PARTNERSHIP Herstellung von Untereinheiten von Pseudorabiesvirus-Vakzinen
US4711850A (en) * 1986-01-28 1987-12-08 Novagene, Inc. Pseudorabies virus mutants, vaccines containing same, methods for the production of same and methods for the use of same
EP0261940A3 (de) * 1986-09-23 1989-07-05 Applied Biotechnology, Inc. Pseudorabies-Impfstoffe und DNS-Vektoren zur Rekombination mit Poxviren

Also Published As

Publication number Publication date
DE68920502D1 (de) 1995-02-23
US5449765A (en) 1995-09-12
EP0353809B1 (de) 1995-01-11
ES2069574T3 (es) 1995-05-16
JPH02142737A (ja) 1990-05-31
US5196516A (en) 1993-03-23
EP0353809A1 (de) 1990-02-07
DE68920502T2 (de) 1995-05-18

Similar Documents

Publication Publication Date Title
DE69434295D1 (de) Von menschlichen T-Zellen immunodominante Epitopen des Virus der C-Hepatitis
DE3278344D1 (en) Stabilization of influenza virus vaccine
DE68929478D1 (de) Rekombinante CMV-Neutralisierungsproteine
DK0677114T3 (da) Rekombinant svinekoppevirus
DE69333397D1 (de) Retro-, inverso-, und retro-inverso synthetische peptidanaloge
DK421687A (da) Vektorvirus, der baerer en heterolog dna-sekvens
FR2620459B1 (fr) Virus recombinant de la vaccine
ATE116860T1 (de) Pseudorabiesvirus-impfstoff.
ES8704975A1 (es) Un procedimiento para preparar un polipeptido que se puede utilizar en una vacuna para proteger seres humanos contra infeccion por plasmodium falciparum
DK665688D0 (da) Polypeptid
ATE147100T1 (de) Ehv-4 glykoprotein vazin
ES2196018T3 (es) Vacunas de adenovirus recombinantes.
EP0332241A3 (en) Live combination vaccine
ATE205220T1 (de) Hepatitis-a-impfstoff
ES2009587A6 (es) Un metodo para purificar un polipeptido.
ES2053704T3 (es) Un metodo de estabilizacion de una composicion acuosa consistente en uno o mas anticuerpos monoclonales.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties